Latest News

  • 22 Oct 2020
    ONCURIOUS NV Announces First Preclinical Proof of Concept in Proprietary CCR8 Treg Program
  • 11 Jun 2019
    ONCURIOUS NV Receives Project Grant from VLAIO to Progress its Pipeline of Next Generation Cancer Immunotherapies